期刊文献+

血清cTnⅠ联合Hcy对非ST段抬高心肌梗死个体化诊断的价值研究 被引量:4

Study on value of combination detection of cardiac troponins Ⅰ and homocysteine in individual diagnosis of non-ST elevation myocardial infarction
下载PDF
导出
摘要 目的探讨心肌钙蛋白I(cTnI)与同型半胱氨酸(Hcy)联合检测对提高非ST段抬高心肌梗死(NSTEMI)诊疗效果的作用。方法检测47例NSTEMI患者(NSTEMI组)在治疗前、后及63例健康体检者(对照组)的cTnI和Hcy水平,并通过统计学方法验证这两项指标对于判断NSTEMI诊疗效果的价值。结果 NSTEMI组血清cTnI为(2.37±0.65)ng/mL、Hcy为(19.23±2.94)μmol/L,均显著高于对照组的cTnI(0.33±0.14)ng/mL、Hcy(10.62±3.27)μmol/L,两组比较差异有统计学意义(P<0.05);单一cTnI与Hcy指标检测灵敏度分别为95.74%和85.11%,特异性分别为85.71%和90.48%;两项指标联合检测的灵敏度与特异性达到97.87%和98.41%;NSTEMI组治疗后的cTnI和Hcy水平均显著下降并接近正常水平。结论 cTnI和Hcy联合检测不仅可用于NSTEMI的诊断,而且对于NSTEMI的疗效判断具有重要意义。 Objective To discuss the effect of the combination detection of cardiac troponin I(cTnI) and homocysteine(Hcy) for increasing the diagnosis and treatment offects of non-ST elevation myocardial infarction(NSTEMI). Methods The levels of cTnI and Hcy were detected in 4? patients with NSTEMI(NSTEMI group) before and after therapy and 63 healthy individuals(control group). The detection results were performed the statistical analysis for verifying their value to judge the diagnostic and treatment effect of NSTEMI. Results The levels of cTnI and Hcy were(2.37±0.65)ng/mL and(19.23±2.94) μmol/L in the NSTEMI group, which were significantly higher than(0.33 ±0. 14) ng/mL and ( 10.62± 3.27)μmol/L in the control group, the differences showing statistical significance(P〈0.05);the sensitivities of single cTnI and Hcy were 95.74% and 85. 11%0 respectively, and their specificities were 85.71% and 90.48% respectively; the sensitivity and sepecificity of cTnI and Hey combination detection were risen to 97.87% and 98.41%respectively; after therapy, the cTnI and Hcy levels in the NSTEMI group were significantly lowered and close to the normal levels. Conclusion The combination detection of cTnI and Hcy can not only be used for the diagno- sis of NSTEMI,but also has the imoortant significance to the Judgment of the theraneNtiel effect of NSTEMI
出处 《重庆医学》 CAS CSCD 北大核心 2014年第11期1293-1295,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(30972819)
关键词 心肌钙蛋白 同型半胱氨酸 非ST段抬高心肌梗死 cardiac troponins homocysteine non-ST elevation myocardial infarction
  • 相关文献

参考文献12

  • 1Jneid H. The 2012 ACCF/AHA Focused Update of the Unstable Angina/Non-ST-Elevation Myocardial Infarc- tion(UA/NSTEMI) Guideline: a critical appraisal [ J ]. Methodist Debakey Cardiovasc J ,2012,8(3) :26-30.
  • 2Nevado JB Jr, Imasa MS. Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction., implications from the folate inter- vention in non-ST elevation myocardial infarction and un- stable angina study [ J ]. Coron Artery Dis, 2008, 19 ( 3 ) : 153-161.
  • 3Daga LC, Kaul U, Mansoor A. Approach to STEMI and NSTEMI[J]. J Assoc Physicians India, 2011,59 Suppl: S19-25.
  • 4Nanni C, Taglieri N, Bonfiglioli R, et al. Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST- segment elevation myocardial infarction (NSTEMI) [J].Eur J Nucl Med Mol Imaging,2013,40(4):642-643.
  • 5Vizzardi E, Nodari S, Fiorina C, et al. Plasma homocys- teine levels and late outcome in patients with unstable an- gina[J]. Cardiology, 2007,107 (4) : 354-359.
  • 6Hall TS, Hallen J, Agewall S, et al. Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience[J]. Clin Lab, 2012, 58 (10) : 1029-1036.
  • 7Vavuranakis M, Kariori MG, Kalogeras KI, et al. Biomar- kers as a guide of medical treatment in cardiovascular dis- eases[J]. Curr Med Chem, 2012,19(16) : 2485-2496.
  • 8de Antonio M, Lupon J, Galan A, et al. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of per- formance over established mortality risk factors in chronic heart failure[J]. Am Heart J, 2012,163(5) : 821-828.
  • 9Ferraro S, Ardoino I, Boracchi P, et al. Inside ST-elevation myocardial infarction by monitoring concentrations of car- diovascular risk biomarkers in blood[J]. Clin Chem Acta, 2012,413(9/10) :888-893.
  • 10Christ M, Popp S, Pohlmann H, et al. Implementation of high sensitivity cardiac troponin T measurement in the e- mergency department [J]. Am J Med, 2010, 123 ( 12 ): 1134-1142.

同被引文献39

  • 1胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2003:485.
  • 2Song Y, Wang HJ, Ma J, et al. Secular trends of obesity prevalence in urban Chinese children from 1985 to 2010: gender disparity []~. PLoSOne, 2013, 8 (1): e53069.
  • 3Hirsch R, Landt Y, porter S, et al. Cardiac troponin I in pediatrics: normal values and potential use in the assessment o~cardiac [J]. J Pediatr, 1997, 130 (6): 872-877.
  • 4Eggers KM, Johnston, N, James, S, et al. Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-The importance of gender F J3. Am Heart J, 2014, 168 (3): 317-Ul11.
  • 5Paul M, Omar F, Christopher G, et al. High-sensitivity troponin I and amino-terminal pro-B-type natriuretic peptide predict heart failure and mortality in the generalpopulation [J]. ClinChem, 2014, 60 (9): i225-1233.
  • 6Suleiman M, Khatib R, inflammation and risk of failure and mortality in Agmon Y, et al. Early long-term development of heart survivors of acute Myocardial infarction: predictive role of C-reactive protein [J]. J Am Coll Cardiol, 2006, 47 (5): 962-968.
  • 7McLaughlin T, Abbasi F, Lamendola Differentiation between obesity and insulin resistance in the association with C-reactive protein [J]. Circulation, 2007, 101, 1696-1701.
  • 8李彦华,许强.体质指数与老年心力衰竭患者血浆脑利钠肽水平的相关性研究[J].临床心血管病杂志,2010,26(4):262-264. 被引量:14
  • 9包乌仁吐亚,武彦,耿虹,杨帆,刘扬,李瑞全,贾富全,张杰.心肌钙蛋白Ⅰ与脑钠肽在心肌梗死组织中的表达及其意义[J].包头医学院学报,2011,27(5):7-9. 被引量:1
  • 10叶舟,牛丽丽.B型钠尿肽在非ST段抬高心肌梗死患者临床早期诊断及预后的价值[J].中华老年心脑血管病杂志,2012,14(4):380-382. 被引量:8

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部